Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on May 20, 2025
Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth
GlobeNewswire
·
May 20, 2025
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Segra International (“Segra”), a global leader in cannabis agriculture technology, proudly announces its strategic amalgamation with Klonetics Plant Science Inc., a licensed cannabis nursery and …
Global Alzheimer’s Platform Foundation Applauds FDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimer’s Disease
GlobeNewswire
·
May 20, 2025
WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose Alzheimer’s disease. Fujirebio’s Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio invitro …
Glimmery Moments Launches ‘Slow Summer’ Paper Collection to Support Accessible Behavior Change Toward Offline Living
EIN Presswire
·
May 20, 2025
Dutch brand Glimmery Moments launches seasonal paper rituals to help people reconnect, reduce screen time, and restore focus — offline. ROTTERDAM, ZUID-HOLLAND, NETHERLANDS, May 20, 2025 /EINPresswire.com/ -- In 2025, the desire to disconnect is …
TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the “Outstanding Patient Recruitment and Retention” Category
GlobeNewswire
·
May 20, 2025
SAN FRANCISCO, May 20, 2025 (GLOBE NEWSWIRE) -- TrialWire today announces it was named a Fierce CRO Award finalist by Fierce Biotech in the Outstanding Patient Recruitment and Retention category. TrialWire is the AI and algorithm-powered patient- …
Von Vascular Announces Publication of ALGO™ Smart Pump Study in Clinical Neurology and Neurosurgery
EIN Presswire
·
May 20, 2025
Von Vascular’s ALGO™ Smart Pump study shows superior complete clot ingestion in pre-clinical stroke study, published in 'Clinical Neurology and Neurosurgery'. SUNRISE, FL, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Von Vascular, Inc., a medical …
Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
GlobeNewswire
·
May 20, 2025
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company's corporate credit rating to BB+, with a stable outlook; from BB. Fitch's report cites …
Neuphoria Provides First Quarter 2025 Business Updates
GlobeNewswire
·
May 20, 2025
Cash runway into Q3 2026 AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025 α7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck and in Phase 2 clinical trial in Alzheimer’s …
XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness
GlobeNewswire
·
May 20, 2025
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a pioneer in science-proven, accessible wellness, today reported results for the first quarter ended March 31, 2025. With a growing portfolio of in-airport …
CooperCompanies’ 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet
GlobeNewswire
·
May 20, 2025
SAN RAMON, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (“Cooper”) (Nasdaq: COO), a leading medical device company, published its 2024 Sustainability Report. The report showcases the company’s initiatives to foster positive change for both …
GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l’approbation du prix et du remboursement d’Iqirvo® par Ipsen en Italie
GlobeNewswire
·
May 20, 2025
Lille (France), Cambridge (Massachusetts, Etats-Unis), Zurich (Suisse), le 20 mai, 2025 – GENFIT (Nasdaq et Euronext : GNFT), société́ biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares …
GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
GlobeNewswire
·
May 20, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
GlobeNewswire
·
May 20, 2025
ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate …
Amerigo Scientific Introduces Electrospun Polycaprolactone Scaffolds for 3D Cell Culture
EIN Presswire
·
May 20, 2025
Amerigo Scientific has unveiled its 3D electrospun polycaprolactone (PCL) scaffolds tailored for 3D cell culture applications. NEW YORK, NY, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Amerigo Scientific has unveiled its 3D electrospun …
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
GlobeNewswire
·
May 20, 2025
SUNNYVALE, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane …
INVO Fertility Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 20, 2025
SARASOTA, Fla., May 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
Tactile Medical to Present at Upcoming Investor Conferences in June
GlobeNewswire
·
May 20, 2025
MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be …
Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with…
GlobeNewswire
·
May 20, 2025
REDWOOD CITY, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced data presented from its clinical development …
Medicine Repurposing Enables Value-Based Insomnia And Pain Therapy; Olumuyiwa Bamgbade, Salem Pain Clinic, Canada
EIN Presswire
·
May 20, 2025
A Promising Case of Medicine Repurposing: Clonidine for Insomnia in Chronic Pain Patients. Olumuyiwa Bamgbade, Salem Pain Clinic, BC, Canada. SURREY, BC, CANADA, May 20, 2025 /EINPresswire.com/ -- In this era where value-based healthcare is shaping the …
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124
GlobeNewswire
·
May 20, 2025
There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult to treat and life-threatening Skin Cancer Awareness Month in May shines a spotlight on the growing burden of advanced skin cancers …
Avalyn Showcases Clinical Data Across Multiple Pulmonary Fibrosis Programs at ATS 2025
GlobeNewswire
·
May 20, 2025
Topline results for AP02 (inhaled nintedanib) confirmed safety and tolerability with limited systemic exposure and substantially improved lung exposure compared to oral nintedanib AP01 (inhaled pirfenidone) treatment demonstrated long-term antifibrotic …